Nav Health Semaglutide Review

Nav Health publishes both sides of the price: what insurance covers and what you pay without it. Our research (August 8, 2026) found a broad telehealth primary care service with unusually direct cost disclosure.

Insurance Plus Published Cash Prices

The company's own framing is "Insurance accepted, up-front pricing, no hidden fees," and it follows through with figures:

• $150 without insurance for a visit
• $100 without insurance for a prescription renewal

Publishing both an insurance pathway and a cash price is rare. Most operators in this category do one or the other, and patients without the right plan are left guessing. Here, an uninsured patient knows the number before booking.

A LillyDirect Telehealth Partner

Nav Health appears on LillyDirect's list of independent telehealth partners, where Lilly publishes its pricing as $59/month self-pay on an annual subscription with access to labs and wellness content. Two things follow. First, being listed by Lilly suggests a working relationship with the manufacturer-direct pharmacy channel — useful if you want brand-name Zepbound rather than a compounded copy. Second, the $59/month annual subscription is a different product from the $150 per-visit cash price, so establish which you are buying. Lilly is explicit that these partners are independent companies charging their own fees, and that using one is not required.

Broad Primary Care Scope

Nav Health covers dermatology, lab tests, prescriptions, ongoing care, preventive care and specialty consults, stating that "our clinicians work directly with a specialist to get you an answer in hours, not months." Patients can see lab costs up front and book instantly, and prescriptions are written and sent to the patient's own pharmacy. That last detail matters: sending a prescription to your pharmacy rather than to a captive fulfilment partner means you can shop the price — including through LillyDirect or NovoCare. Care is described as delivered by board-certified clinicians who review recommendations and provide personalised guidance.

What We Could Not Establish

The GLP-1 offering specifically is thinly documented. We found no BMI or eligibility criteria, no statement of whether prescriptions would be brand-name or compounded, no dosing protocol, no monitoring schedule, no list of accepted insurers, and no state coverage list. Given the model — prescriptions sent to your own pharmacy, plus a LillyDirect partnership — brand-name is the likely route, but confirm it. The breadth of the service is also worth weighing. A platform covering dermatology, specialty referrals, preventive care and prescriptions is a general primary care service rather than a weight-management practice, which cuts both ways: better clinical context, less specialist depth in obesity medicine.